54 related articles for article (PubMed ID: 8096076)
1. Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity.
Smith K; Houlbrook S; Greenall M; Carmichael J; Harris AL
Oncogene; 1993 Apr; 8(4):933-8. PubMed ID: 8096076
[TBL] [Abstract][Full Text] [Related]
2. The expression and prognostic significance of Topo-II and c-erbB-2 in breast cancer.
Hua S; Chuanbo F; Zhonglin W; Shuangjiu Z; Xinwen Z
Minerva Med; 2020 Jul; ():. PubMed ID: 32683851
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and evaluation of a mitoxantrone probe (MXP) for biological studies.
Wallin S; Singh S; Borgstahl GEO; Natarajan A
Bioorg Med Chem Lett; 2023 Oct; 94():129465. PubMed ID: 37669721
[TBL] [Abstract][Full Text] [Related]
4. In Silico and In Vitro Studies of Novel Azomethines on DNA Repair Genes in Gastric Cell Lines.
Ozturk A; Agbektas T; Huseynzada A; Guliyev R; Ganbarova R; Hasanova U; Tas A; Erkan S; Zontul C; Inandiklioglu N; Silig Y
Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895364
[TBL] [Abstract][Full Text] [Related]
5. A careful reassessment of anthracycline use in curable breast cancer.
Hurvitz SA; McAndrew NP; Bardia A; Press MF; Pegram M; Crown JP; Fasching PA; Ejlertsen B; Yang EH; Glaspy JA; Slamon DJ
NPJ Breast Cancer; 2021 Oct; 7(1):134. PubMed ID: 34625570
[TBL] [Abstract][Full Text] [Related]
6. MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy.
Calhoun BC; Portier B; Wang Z; Minca EC; Budd GT; Lanigan C; Tubbs RR; Morrison LE
BMC Cancer; 2016 Aug; 16(1):695. PubMed ID: 27576528
[TBL] [Abstract][Full Text] [Related]
7. Triple-negative breast cancer exhibits a favorable response to neoadjuvant chemotherapy independent of the expression of topoisomerase IIα.
Nogi H; Uchida K; Kamio M; Kato K; Toriumi Y; Akiba T; Morikawa T; Suzuki M; Kobayashi T; Takeyama H
Mol Clin Oncol; 2016 Mar; 4(3):383-389. PubMed ID: 26998288
[TBL] [Abstract][Full Text] [Related]
8. Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer.
Iyikesici MS; Basaran G; Dane F; Ekenel M; Yumuk PF; Cabuk D; Teomete M; Turhal NS
Int J Clin Exp Med; 2014; 7(5):1459-64. PubMed ID: 24995112
[TBL] [Abstract][Full Text] [Related]
9. Correlation between ER, PR, HER-2, Bcl-2, p53, proliferative and apoptotic indexes with HER-2 gene amplification and TOP2A gene amplification and deletion in four molecular subtypes of breast cancer.
Mitrović O; Čokić V; Đikić D; Budeč M; Vignjević S; Subotički T; Gulan M; Radović S; Furtula S
Target Oncol; 2014 Dec; 9(4):367-79. PubMed ID: 24272208
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of the growth inhibition activity of 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) by Herceptin in SKBR-3 human breast cancer cells.
Sun YW; Niu TK; Yang JM; Kwon CH; Chen KY; Chen KM
Exp Ther Med; 2010 May; 1(3):513-518. PubMed ID: 22993569
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
Betof AS; Rabbani ZN; Hardee ME; Kim SJ; Broadwater G; Bentley RC; Snyder SA; Vujaskovic Z; Oosterwijk E; Harris LN; Horton JK; Dewhirst MW; Blackwell KL
Br J Cancer; 2012 Feb; 106(5):916-22. PubMed ID: 22333602
[TBL] [Abstract][Full Text] [Related]
12. Dietary isothiocyanate-induced apoptosis via thiol modification of DNA topoisomerase IIα.
Lin RK; Zhou N; Lyu YL; Tsai YC; Lu CH; Kerrigan J; Chen YT; Guan Z; Hsieh TS; Liu LF
J Biol Chem; 2011 Sep; 286(38):33591-600. PubMed ID: 21828038
[TBL] [Abstract][Full Text] [Related]
13. Translational control of TOP2A influences doxorubicin efficacy.
Srikantan S; Abdelmohsen K; Lee EK; Tominaga K; Subaran SS; Kuwano Y; Kulshrestha R; Panchakshari R; Kim HH; Yang X; Martindale JL; Marasa BS; Kim MM; Wersto RP; Indig FE; Chowdhury D; Gorospe M
Mol Cell Biol; 2011 Sep; 31(18):3790-801. PubMed ID: 21768308
[TBL] [Abstract][Full Text] [Related]
14. GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays.
Li A; Liu Z; Lezon-Geyda K; Sarkar S; Lannin D; Schulz V; Krop I; Winer E; Harris L; Tuck D
Nucleic Acids Res; 2011 Jul; 39(12):4928-41. PubMed ID: 21398628
[TBL] [Abstract][Full Text] [Related]
15. Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.
Press MF; Sauter G; Buyse M; Bernstein L; Guzman R; Santiago A; Villalobos IE; Eiermann W; Pienkowski T; Martin M; Robert N; Crown J; Bee V; Taupin H; Flom KJ; Tabah-Fisch I; Pauletti G; Lindsay MA; Riva A; Slamon DJ
J Clin Oncol; 2011 Mar; 29(7):859-67. PubMed ID: 21189395
[TBL] [Abstract][Full Text] [Related]
16. Testing for HER2 in Breast Cancer: A Continuing Evolution.
Shah S; Chen B
Patholog Res Int; 2010 Dec; 2011():903202. PubMed ID: 21188214
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
Harris LN; Broadwater G; Abu-Khalaf M; Cowan D; Thor AD; Budman D; Cirrincione CT; Berry DA; Winer EP; Hudis CA; Hayes DF; Friedman P; Ellis M; Dressler L
J Clin Oncol; 2009 Jul; 27(21):3430-6. PubMed ID: 19470942
[TBL] [Abstract][Full Text] [Related]
18. Targeting DNA topoisomerase II in cancer chemotherapy.
Nitiss JL
Nat Rev Cancer; 2009 May; 9(5):338-50. PubMed ID: 19377506
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of breast cancer progression.
Dairkee SH; Smith HS
J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):139-51. PubMed ID: 10887488
[TBL] [Abstract][Full Text] [Related]
20. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo.
Zhang HT; Scott PA; Morbidelli L; Peak S; Moore J; Turley H; Harris AL; Ziche M; Bicknell R
Br J Cancer; 2000 Jul; 83(1):63-8. PubMed ID: 10883669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
